CONVERGE is studying patients with locally advanced non-small cell lung cancer who are receiving chemoradiation followed by ...
CONVERGE randomizes patients to standard concurrent chemoradiation followed by durvalumab versus the same regimen plus intratumoral JNJ-1900, aiming to improve efficacy while characterizing safety ...
This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...
Lung cancer incidence decreased 3.5%/year in males and 1.9%/year in females during 2018–2022, alongside a two-thirds increase ...
Natera and its collaborators recently presented four abstracts at the IASLC 2026 World Conference on Lung Cancer, including the largest molecular residual disease dataset to date in resected stage 1–3 ...
We share the story of Shin Sung-hwi, 63 years old, Seongbuk-gu, Seoul, who overcame stage 3 lung cancer. After her cancer ...
In stage II–IIIA disease, adjuvant osimertinib reduced mortality risk by 47%, with 74% alive at eight years versus 58% with ...
The Female Asian Nonsmoker Screening Study (FANSS) showed a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history. The findings of FANSS, the largest lung cancer screening ...
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results